QURE: uniQure NV Company Aggregate Debts

Symbol and logo of brand uniQure (QURE)

The daily price chart for uniQure N.V. (QURE) reflects debt dynamics, which currently stand at 0.56. uniQure N.V. was the first to implement gene correction for hemophilia, replacing years of therapy with a single injection to generate excess profits. Currently, the R&D center is focusing on AAV vectors to combat Huntington's disease, establishing a foundation for treating rare pathologies. High procedure costs and patent protection provide strong momentum, ensuring maximum product margins.

Company Debts: uniqure.com (QURE) for 07/04/2022 - 10/31/2026

Metric breakdowns and analytics for uniQure (QURE)

- stock price and consensus target price:
Share Price uniQure Pharma|QURE - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization uniQure Corp|QURE - Real Price to Acquire Entire Company
- balance sheet equity data:
Book Value per Share uniQure|QURE - Company Book Value|Capitalization to Book Value Ratio uniqure.com|QURE - Company Total Assets
- business debt structure and liquidity details:
Total Debt to Capital Coefficient uniQure N.V.|QURE - Long-Term Debt to Equity|Short-Term Indebtedness to Equity uniQure NV|QURE - Company Total Debt|Debts to Book Capitalization uniQure Corp|QURE - Company Long-Term Debt|Company Short-Term Loans and Borrowings uniQure|Immediate Liquidity uniqure.com
- company profitability and valuation multiples indicators:
QURE - Net Income
Summary company analytics:QURE uniQure Pharma
Core merchandise of uniQure

Maintaining the core team of gene therapy researchers requires significant capital expenditures in R&D for uniQure N.V. (QURE). This indicator captures the total volume of confirmed financial obligations, excluding subjective estimates. By analyzing the debt load status, the investor sees the real dynamics of borrowings and the speed of their repayment. A declining curve confirms the financial recovery of the business. Market consensus links this trend to the stability of the company's operating model.

Competitors of uniQure N.V.

Tempus AI, Inc. - Company Aggregate Debt|Company Aggregate Debts QGEN (Qiagen N.V.)|Company Aggregate Debts ionispharma.com IONS|RGEN: Company Total Debt|RNA - Company Aggregate Debts|CRISPR Therapeutics Corp (CRSP) - Company Debts|Company Aggregate Debt WGS|RARE (Ultragenyx Pharmaceutical) - Company Aggregate Debts|beamtx.com (BEAM) - Company Total Debt Obligations|Company Debts Sarepta (SRPT)|Twist Bioscience Inc (TWST) - Company Total Indebtedness|10x Genomics Corp - Company Total Debt|Company Aggregate Debts Intellia Corp NTLA|STOK - Company Debts|Aggregate Debt Obligations BLFS (biolifesolutions.com)|WVE: Company Aggregate Debts|Company Cumulative Debt Maze Therapeutics, Inc. (MAZE)|Company Total Debt SION|PRME: Aggregate Debt Obligations|Company Debts Taysha Gene Therapies (TSHA)|meiragtx.com - Company Aggregate Debt|REGENXBIO - Company Total Debt|Company Total Debt Obligations Solid Biosciences Inc (SLDB)|OCGN: Company Total Debt|PACB: Company Debts|BNTC (Benitec Biopharma Inc.) - Company Total Debt|DSGN - Company Total Debt Obligations|Company Debts Rocket Pharmaceuticals, Inc.|FDMT - Company Total Indebtedness|Company Total Debt LXEO (Lexeo Therapeutics)|Company Aggregate Debts korrobio.com (KRRO)|Company Debts Editas Medicine, Inc. EDIT|Aggregate Debt Obligations SLN|ProQR Therapeutics NV - Company Aggregate Debts|Company Cumulative Debt Codexis, Inc.|SGMO: Company Aggregate Debts|Company Aggregate Debt NAUT|Company Debts Metagenomi, Inc.|Company Aggregate Debt DTIL (precisionbiosciences.com)|Company Aggregate Debts GBIO|Company Aggregate Debts Boundless Bio Inc. (BOLD)|Exicure - Company Total Debt|Company Aggregate Debts Imunon Inc IMNN|PHIO - Company Debts|MBIO (Mustang Bio, Inc.) - Company Aggregate Debt|RNAZ: Company Aggregate Debts|BNGO - Company Total Debt Obligations|Company Debts Applied DNA|BLUE - Company Total Indebtedness|Company Total Debt IPA (ImmunoPrecise Antibodies)|Company Aggregate Debts omegatherapeutics.com (OMGA)|Company Debts Singular Genomics OMIC|Aggregate Debt Obligations RGLS|Syros - Company Aggregate Debts|Company Cumulative Debt Telesis Bio, Inc|TCON (TRACON Pharmaceuticals) - Company Total Debt|unitybiotechnology.com - Aggregate Debt Obligations